Suchergebnisse - "Fece de la Cruz, Ferran"

PubPharm (11)

1

Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations

enthalten in: Cancer discovery | 2024

von Varkaris, A. | Fece de la Cruz, F. | Martin, E. | +28

2

Sotorasib is a pan-RASG12C inhibitor capable of driving clinical response in NRASG12C cancers

enthalten in: Cancer discovery | 2024

von Rubinson, D. | Tanaka, N. | Fece de la Cruz, F. | +10

3

Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Wu, Q. | Ellis, H. | Siravegna, G. | +9

4

Vertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRASG12C Inhibition

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Ryan, M. | Fece de la Cruz, F. | Phat, S. | +5

CommentIn: Clin Cancer Res. 2020 Apr 1;26(7):1538-1540. - PMID 32001483

5

Co-occurring Alterations in the RAS-MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Rotow, J. | Gui, P. | Wu, W. | +22

6

TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma

enthalten in: Cancer discovery | 2019

von Goyal, L. | Shi, L. | Liu, L. | +39

7

Epigenetic and transcriptional dysregulation of VWA2 associated with a MYC-driven oncogenic program in colorectal cancer

enthalten in: Scientific reports | 2018

von González, B. | Fece de la Cruz, F. | Samuelsson, J. | +2

8

MEK inhibitors block growth of lung tumours with mutations in ataxia-telangiectasia mutated

enthalten in: Nature communications | 2016

von Smida, M. | Fece de la Cruz, F. | Kerzendorfer, C. | +13

9

Synthetic lethal vulnerabilities of cancer

enthalten in: Annual review of pharmacology and toxicology | 2015

von Fece de la Cruz, F. | Gapp, B. | Nijman, S.

10

Synthetic lethal vulnerabilities of cancer

enthalten in: Annual review of pharmacology and toxicology | 2015

von Fece de la Cruz, F. | Gapp, B. | Nijman, S.